“Raleigh-based Salix Pharmaceuticals has agreed to be acquired by Canadian drugmaker Valeant Pharmaceuticals in a deal valued at some $14 billion.  The boards of both companies have already agreed to the terms, which were announced Sunday” according to WRAL TechWire.  Valeant said in a statement that the acquisition means strong growth, as Salix has focused on developing drugs to treat gastrointestinal diseases.  For more information, please visit:  http://wraltechwire.com/raleigh-based-salix-pharmaceutical-being-acquired-in-14b-deal/14464120/